Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cerebral Glioma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)UnknownNCT00591058
What this trial is testing

Safety and Dose-Finding Study of TM-601 in Adults With Recurrent Malignant Glioma

Who this might be right for
Malignant GliomaGlioblastoma MultiformeGBM+2 more
TransMolecular 36
Not applicableStudy completedNCT00897663
What this trial is testing

Improving the Selection of Patients With Glioblastoma Multiforme for Treatment With Epidermal Growth Factor Receptor Inhibitor Therapies

Who this might be right for
Brain and Central Nervous System Tumors
Alliance for Clinical Trials in Oncology 56
Early research (Phase 1)Study completedNCT01234740
What this trial is testing

Bafetinib in Treating Patients With Recurrent High-Grade Glioma or Brain Metastases

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic Oligodendroglioma+7 more
City of Hope Medical Center 7
Large-scale testing (Phase 3)UnknownNCT00256425
What this trial is testing

Cognitive Rehabilitation of Glioma Patients

Who this might be right for
GliomaCognition Disorders
UMC Utrecht 140
Testing effectiveness (Phase 2)Study completedNCT00540176
What this trial is testing

The Safety and Efficacy of DCA for the Treatment of Brain Cancer

Who this might be right for
Malignant Gliomas, Glioblastoma Multiforme
University of Alberta 40
Testing effectiveness (Phase 2)Study completedNCT01339052
What this trial is testing

Phase II Study of BKM120 for Subjects With Recurrent Glioblastoma

Who this might be right for
Glioblastoma
L. Nicolas Gonzalez Castro, MD, PhD 65
Early research (Phase 1)Ended earlyNCT00734526
What this trial is testing

Phase I Portion of Phase I/II Sorafenib With Radiation and Temozolomide in Newly Diagnosed Glioblastoma or Gliosarcoma

Who this might be right for
GlioblastomaGliosarcoma
M.D. Anderson Cancer Center 18
Testing effectiveness (Phase 2)Looking for participantsNCT02861898
What this trial is testing

Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma

Who this might be right for
GlioblastomaBrain CancerBrain Neoplasm+4 more
Northwell Health 33
Early research (Phase 1)Active Not RecruitingNCT04837547
What this trial is testing

PEACH TRIAL- Precision Medicine and Adoptive Cellular Therapy

Who this might be right for
NeuroblastomaDiffuse Intrinsic Pontine Glioma
University of Florida 24
Not applicableStudy completedNCT03551249
What this trial is testing

Assessment of Safety and Feasibility of ExAblate Blood-Brain Barrier (BBB) Disruption

Who this might be right for
GliomaGlioblastoma
InSightec 20
Testing effectiveness (Phase 2)Study completedNCT00003185
What this trial is testing

Biological Therapy in Treating Patients With Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
The Cleveland Clinic 40
Testing effectiveness (Phase 2)Study completedNCT04911621
What this trial is testing

Adjuvant Dendritic Cell Immunotherapy for Pediatric Patients With High-grade Glioma or Diffuse Intrinsic Pontine Glioma

Who this might be right for
High Grade GliomaDiffuse Intrinsic Pontine Glioma
University Hospital, Antwerp 10
Testing effectiveness (Phase 2)Ended earlyNCT00548938
What this trial is testing

Gliadel Wafer, Temozolomide and Radiation Therapy for Newly Diagnosed GBM

Who this might be right for
Glioblastoma MultiformeHigh-Grade Glioma
Methodist Healthcare - Memphis 40
Early research (Phase 1)Study completedNCT00049023
What this trial is testing

Radiolabeled Octreotide in Treating Children With Advanced or Refractory Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsGastrointestinal Carcinoid TumorIslet Cell Tumor+4 more
O'Dorisio, M S 27
Not applicableLooking for participantsNCT07413796
What this trial is testing

Comparison of Skin Closure Techniques in Oncological Neurosurgical Procedures: Intradermal Running Suture Versus Transdermal Interrupted Sutures

Who this might be right for
Brain Tumor AdultBrain Tumor BenignMeningioma+2 more
Medical University of Warsaw 382
Testing effectiveness (Phase 2)Ended earlyNCT01116661
What this trial is testing

Safety Study of Aminolevulinic Acid (ALA) to Enhance Visualization and Resection of Tumors of the Brain

Who this might be right for
Glioma
University of California, San Francisco 199
Early research (Phase 1)Ended earlyNCT01989052
What this trial is testing

Ph 1/2 CTO With Lomustine for Bevacizumab-Naive Recurrent Glioma

Who this might be right for
Malignant Glioma (WHO Grade III or IV)
Annick Desjardins 9
Not applicableLooking for participantsNCT05259605
What this trial is testing

Observational Study for Assessing Treatment and Outcome of Patients With Primary Brain Tumours Using cIMPACT-NOW and 2021 WHO Classification

Who this might be right for
GliomaGlioneuronal TumorChoroid Plexus Tumor+10 more
European Organisation for Research and Treatment of Cancer - EORTC 1,650
Very early researchActive Not RecruitingNCT05023551
What this trial is testing

Study of DSP-0390 in Patients With Recurrent High-Grade Glioma

Who this might be right for
High Grade GliomaGlioblastoma Multiforme
Sumitomo Pharma America, Inc. 39
Testing effectiveness (Phase 2)Study completedNCT03779230
What this trial is testing

Safety and Efficacy of L19TNF in Patients With Isocitrate Dehydrogenase (IDH) Wildtype WHO Grade III / IV Glioma at First Relapse

Who this might be right for
Glioma of Brain
Philogen S.p.A. 20
Next Page